Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Behavioral: Physical activity plus positive affect
Behavioral: Physical activity plus education

First Posted Date: 2016-04-29

Last Posted Date: 2018-02-07

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 29

Registration Number: NCT02755883

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Trial to Compare Radiation Fibrosis With Five Versus Three Fractions

Phase 2

Active, not recruiting

Conditions: Malignant Neoplasm of Breast Stage I

Interventions: Radiation: Arm 1 600 cGY x 5 fractions
Radiation: Arm 2 800 cGY x 3 fractions

First Posted Date: 2016-04-29

Last Posted Date: 2024-02-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 350

Registration Number: NCT02755896

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Brooklyn Methodist Hospital - NewYork Presbyterian, New York, New York, United States

and more 1 locations

Venous Sinus Stenting To Treat Intractable Pulsatile Tinnitus Caused By Venous Sinus Stenosis

Not Applicable

Terminated

Conditions: Pulsatile Tinnitus
Venous Sinus Stenosis
Dural Sinus Stenosis
Tinnitus

Interventions: Device: Venous Sinus Stenting with the Precise Pro Stent

First Posted Date: 2016-04-12

Last Posted Date: 2021-04-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 10

Registration Number: NCT02734576

Locations: 🇺🇸
New York Presbyterian Hospital/ Weill Cornell Medicine, New York, New York, United States

Safety of Caprylic Triglycerides in ALS: A Pilot Study

Not Applicable

Completed

Conditions: ALS

Interventions: Dietary Supplement: Axona

First Posted Date: 2016-03-23

Last Posted Date: 2018-04-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 10

Registration Number: NCT02716662

Locations: 🇺🇸
Weill Cornell Medical Center, New York, New York, United States

Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation

Not Applicable

Completed

Conditions: Essential Tremor

Interventions: Drug: RenuGel
Drug: Botulinum Toxin

First Posted Date: 2016-03-17

Last Posted Date: 2018-02-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 8

Registration Number: NCT02711995

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies

Completed

Conditions: Lymphoma

First Posted Date: 2016-03-01

Last Posted Date: 2020-08-17

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 82

Registration Number: NCT02694913

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Neoadjuvant J591 Treatment for Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: huJ591
Drug: 89Zr-J591

First Posted Date: 2016-02-29

Last Posted Date: 2020-10-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 8

Registration Number: NCT02693860

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

Phase 2

Completed

Conditions: Tuberculosis

Interventions: Drug: Nitazoxanide
Other: Control

First Posted Date: 2016-02-17

Last Posted Date: 2020-08-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 30

Registration Number: NCT02684240

Locations: 🇭🇹
Les Centres GHESKIO, Port-au-Prince, Haiti

Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

Phase 3

Withdrawn

Conditions: Immune Thrombocytopenia

Interventions: Drug: Rituximab
Drug: Dexamethasone
Drug: Placebo
Drug: Mycophenolate mofetil

First Posted Date: 2016-01-07

Last Posted Date: 2018-08-14

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT02649504

The Effect of White Noise In High Noise Environment

Not Applicable

Completed

Conditions: Insomnia

Interventions: Other: white noise

First Posted Date: 2016-01-06

Last Posted Date: 2019-06-17

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 10

Registration Number: NCT02647138

Locations: 🇺🇸
Weill Cornell Medical College Center for Sleep, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy